A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 21, 2017

Primary Completion Date

August 9, 2019

Study Completion Date

August 9, 2019

Conditions

Renal ImpairmentHealthy Volunteers

Interventions

DRUG

TAK-954

TAK-954 intravenous infusion.

Trial Locations (4)

PRA Magyarorszag Kft., Budapest

Szent Imre Egyetemi Oktatokorhaz Belgyogyazati Szakmak Matrix Intezet, Budapest

PRA CZ, s.r.o, Prague

Fakultni Nemocnice Hradec Kralove, Hradec Králové